PharmEasy parent API Holdings in talks with SoftBank to raise $100-200 mn

Softbank is still evaluating proposal. The firm aims to acquire a company in the healthcare space and to clear loans raised earlier, says source

API Holdings, the parent company of digital healthcare startup PharmEasy, is reported to have started preliminary talks with SoftBank to raise $100-200 million. The company, which recently acquired Thyrocare, is planning to raise funds to fuel its inorganic growth plans, said sources close to the development.

“SoftBank is still evaluating the proposal. The company is in talks with several investors, and looking to raise the capital to acquire a company in the healthcare space and clear loans it had raised earlier,” said a person aware of the matter. 

PharmEasy and SoftBank declined to comment on the matter.

"The company is growing very fast.